The Morning Brief: Valeant’s Stock Back in the Black for the Year

June 23, 2017   Stephen Taub

The troubled drug maker has enjoyed a big boost since Paulson & Co. founder John Paulson joined the board.

Valeant Pharmaceuticals International is back in the black…at least for the calendar year. The embattled stock that made many high-profile hedge funds poorer is now up about 18 percent over the past three sessions alone since it was announced that …

Subscribe

Subscribers have unlimited access to all online content inc rankings. Start your subscription today - click on the button below.

Subscribe now

Free trial

Taking a free trial will give you access to online content one week (excludes research & rankings). Start your trial today.

Free Trial




Latest Poll

How will hedge funds finish 2017?

 - 73%
 - 11%
 - 15%

View previous results